Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
The Interpretation of the relative Cytotoxic testing for gloves for the
safety of the operator
• Glove Selection factors
• Standards and guidelines for Gloves
• Cytotoxic testing
Glove Properties
• Protection- Chemically and microbiologically
• Fit for Purpose
• Elasticity• Material of Composition
• Tactility
• Hand Specific/Ambidextrous• Colour
• Sizes
• Texture Finish• Cost
Glove Materials
• Latex
• Polychloroprene/ Neoprene
Exceptional elasticity and latex-like feel
• Nitrile
–Good elasticity, high level of chemical protection
• Vinyl
–Good ESD properties but poor levels of chemical protection
Nitritex - Certification and Standards
ISO 9001
Quality
Management
ISO 9001
Quality
Management
ISO 13485
Quality for
Medical
ISO 13485
Quality for
Medical
EU Directive
93/42/EEC
MDD
EU Directive
93/42/EEC
MDD
EU Directive
89/686/EEC
Article 11b
Quality for PPE
EU Directive
89/686/EEC
Article 11b
Quality for PPE
89/686/EEC
Article 10
Gloves
89/686/EEC
Article 10
Gloves
89/686/EEC
Article 10
Garments
89/686/EEC
Article 10
Garments
EN 455
Medical Gloves
EN 455
Medical Gloves
EN 420
PPE Gloves
General
Requirements
EN 420
PPE Gloves
General
Requirements
EN 374
Permeation
and
Penetration
EN 374
Permeation
and
Penetration
EN 388
Abrasion, Cut,
Puncture and
Tear Resistance
EN 388
Abrasion, Cut,
Puncture and
Tear Resistance
EN 14325
Protective
clothing
EN 14325
Protective
clothing
EN 13982-1
Type 5
Protective
clothing
EN 13982-1
Type 5
Protective
clothing
EN 13034
Type 6
Protective
clothing
EN 13034
Type 6
Protective
clothing
REGULATORY
CERTIFICATIONS
REGULATORY
CERTIFICATIONS
UMBERELLA
STANDARDS
UMBERELLA
STANDARDS
DETAILED
STANDARDS
DETAILED
STANDARDS
EN Various
Protective
clothing type
tests
EN Various
Protective
clothing type
tests
EN 374 Permeation and Penetration
• EN 374 Permeation and Penetration - This standard specifies the capability of gloves to protect the user against chemicals and/or micro-organisms. (3 parts)
• EN 374-1: 2003 Protective gloves against chemicals and microorganisms – Part 1: Terminology and performance requirements
• EN 374-2: 2003 Protective gloves against chemicals and microorganisms – Part 2: Determination of resistance to penetration
• EN 374-3: 2003 Protective gloves against chemicals and microorganisms – Part 3: Determination of resistance to permeation by chemicals
Definitions
• Permeation- is the process by which a chemical moves through a protective material on a molecular level
• Penetration is defined in EN374 as the movement of a chemical or micro-organism through porous materials, seams, pinholes or other imperfections in a protective glove material on a non-molecular level
Protection against Chemotherapy Drugs
• EN 374-3: 2003 Protective gloves against chemicals and micro-organisms- Determination of resistance to permeation of chemicals
• ASTM D 6978-05 Standard practice for assessment of resistance of gloves to permeation by chemotherapy drugs
Difference EN 374-3:2003 ASTM D 6978-05 Consequence
Thickness of the test specimens
Sample has to be taken from the palm of the glove.
Sample has to be taken from either the palm or the cuff, whichever is the thinner.
The ASTM requirement ensures that the area of greatest risk is assessed. The cuff is usually the thinnest part of any glove, so gloves tested under EN 374 are not challenged as rigorously.
Test temperature Test to be conducted at a temperature of 23º ±1ºC.
Test to be conducted at a temperature of 35º ±2ºC.
The ASTM standard specifies a test temperature that is 2ºC below body core temperature. This means that the gloves are tested at a temperature similar to that of a human hand.
Test chemicals A minimum of three chemicals must be used for the test. The chemicals are selected from a pre-defined list of 12. None of the predefined chemicals is a chemotherapy drug.
A minimum of nine chemotherapy drugs must be used for the test. Seven of them are predefined by the standard; the other two must be selected from a predefined list.
The EN 374 list of chemicals will not give a representation of how the gloves will perform when challenged by chemotherapy drugs. Users purchasing these gloves for chemo use should be advised to have them tested for suitability.
Permeation limit Breakthrough of the test chemical is deemed to have occurred when the permeation rate has reached 1µg/cm2/min.
Breakthrough of the test chemical is deemed to have occurred when the permeation rate has reached 0.01µg/cm2/min.
The ASTM test limit is set at 1/100th of the EN 374
limit. This requirement is far more stringent and reflects the potential hazard presented by chemotherapy drugs.*
Test time The test time is defined (by EN 374-1) as 480 minutes.
The test time is defined as 240 minutes.
The shorter test time required by ASTM is a relative weakness of the standard.*
*Testing commissioned by Nitritex to ASTM D 6978 is routinely modified to extend the test time to 480 minutes and monitoring is continued beyond the 0.01µg/cm2/min limit to find the time at which the EN 374 limit of 1µg/cm2/min is reached.
Differences between the Standards
Select 3 gloves for testing against each drugSelect 3 gloves for testing against each drug
Measure the glove thickness at palm and cuffMeasure the glove thickness at palm and cuff
Take test samples from the thinnest part of the glove (identify the outer
surface)
Take test samples from the thinnest part of the glove (identify the outer
surface)
Minimum number of test drugs is 9 for each glove type (27 gloves in total)Minimum number of test drugs is 9 for each glove type (27 gloves in total)
7 mandatory drugs plus 2 others (list provided)7 mandatory drugs plus 2 others (list provided)
Samples must be tested per test method set out in ASTM F739-a
(we extended test period from 4 to 8 hours)
Samples must be tested per test method set out in ASTM F739-a
(we extended test period from 4 to 8 hours)
Test is completed when breakthrough occurs or at end of test period,
whichever occurs first
Test is completed when breakthrough occurs or at end of test period,
whichever occurs first
ASTM D 6978-05 Summary
Permeation rate and breakthrough detection time (minutes)
Specified limit 0.01 µg/cm2/Min 0.1 µg/cm2/Min 1.00 µg/cm2/Min
Cisplatinum (Optional) ND ND ND
Carmustine 2 38 ND
Cyclophosphamide ND ND ND
Doxorubicin Hydrochloride ND ND ND
5-Fluorouracil ND ND ND
Methotrexate (Optional) ND ND ND
Etoposide ND ND ND
Paclitaxel ND ND ND
Thio Tepa 47.7 55.6 ND
Cytotoxic Permeation Performance
Product Name: BioClean UltimateTM
Product Code: BUPS
1. Test method used is ASTM F739-a as required under ASTM D 6978-05
2. Specific limit 0.01µg/cm²/min is limit as defined under ASTM D 6978-05
3. Specific limit 1.00µg/cm²/min is limit as defined under EN 374-3:2003
4. Test period under ASTM D6978-05 is 4 hours (240 minutes).
5. Test period under EN 374-3: 2003 is 8 hours (480 minutes).
6. Test period extended to 8 hours (480 minutes) for all permeation rates.
7. ND = Denotes no permeation detected during the 480 minute test period.
BioClean P-ZeroTM
Chemical Permeation Performance against
IPA based Biocide
EN 374-3:2003 1
Specified limit 1.0 µg/cm2/Min
Klercide BioCide* Not Detected after 480 Minutes
Product Name: BioClean P-ZeroTM
Product Code: BPZS
1 EN 374-3:2003 – Protective gloves against chemicals and micro organisms.
Part three: Determination of resistance to permeation by chemicals
* Market Leading Biocidal sterilisation agent
BioClean Double Gloving System
BioClean UltimateTM
& BioClean EmeraldTM
BioClean EmeraldTM - inner glove
• 100% Accelerator-free & Latex-free
• Easy double donning facilitated by smooth outer surface
• Distinctive green colour
BioClean UltimateTM - outer glove
• Provides excellent tactility and sensitivity
• Performs well against chemotherapy drugs
• 100% Latex-free
Product Name: BioClean UltimateTM
& BioClean EmeraldTM
Double Gloving
Product Code: BUPS & BENS
BioClean Double Gloving System
Permeation Against Carmustine
Permeation rate and breakthrough detection time (minutes)
Specified limit 0.01 µg/cm2/Min 0.1 µg/cm2/Min 1.00 µg/cm2/Min
Cisplatinum (Optional) ND ND ND
Carmustine* ND ND ND
Cyclophosphamide ND ND ND
Doxorubicin Hydrochloride ND ND ND
5-Fluorouracil ND ND ND
Methotrexate (Optional) ND ND ND
Etoposide ND ND ND
Paclitaxel ND ND ND
Thio Tepa ND ND ND
1. Test method used is ASTM F739-a as required under ASTM D 6978-05
2. Specific limit 0.01µg/cm²/min is limit as defined under ASTM D 6978-05
3. Specific limit 1.00µg/cm²/min is limit as defined under EN 374-3:2003
4. Test period under ASTM D6978-05 is 4 hours (240 minutes).
5. Test period under EN 374-3: 2003 is 8 hours (480 minutes).
6. Test period extended to 8 hours (480 minutes) for all permeation rates.
7. ND = Denotes no permeation detected during the 480 minute test period.
BioClean UltimateTM
Polychloroprene
BioClean EmeraldTM
Nitrile
BioClean P-ZeroTM
Polychloroprene
Thick Latex****
Palm thickness (Typical) 0.14 0.12 0.17 0.41
Test method EN 374-3:2003* EN 374-3:2003* EN 374-3:2003* EN 374-3:2003*
Specified Limit*** 1.00 µg/cm²/Min 1.00 µg/cm²/Min 1.00 µg/cm²/Min 1.00 µg/cm²/Min
Cisplatinum (Optional) >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) > 180 Min (Class 4)
Carmustine >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) > 60 Min (Class 3)
Cyclophosphamide >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) > 120 Min (Class 4)
Doxorubicin
Hydrochloride >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) > 180 Min (Class 4)
5-Fluorouracil >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) > 180 Min (Class 4)
Methotrexate (Optional) >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) > 180 Min (Class 4)
Etoposide >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) Did Not Test
Paclitaxel >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) Did Not Test
Thio Tepa >480Min (Class 6) >480Min (Class 6) >480Min (Class 6) Did Not Test
Permeation Performance Comparison
Table shows the time in minutes, after exposure to the chemical, at which the permeation rate reaches 1.00 μg/cm2/Min
Nitritex have tested gloves using ASTM6978-05** which has identical methodology to EN374-3:2003 with the following exceptions:
1. ASTM D 6978-05 is developed specifically for the testing of Chemotherapy drugs. EN374-3:2003 is not.
2. ASTM D 6978-05 Tests at 35 degrees Celsius (± 1) against 23 degrees Celsius (± 1) for EN374-3:2003 giving more realistic in use permeation rate
3. ASTMD 6978-05 Tests chemicals on thinnest part of glove. EN374-3:2003 tests the palm, which is always thicker than the cuff area
* EN374-3:2003. Definition: Protective gloves against chemicals and micro organisms. Determination of resistance to permeation by chemicals.
** ASTM D 6978-05. Definition: Standard practice for assessment of resistance of medical gloves to permeation by chemotherapy drugs
*** Nitritex have also conducted testing at 0.1μg/cm²/Min and 0.01 μg/cm²/Min. Results can be furnished on request
Breakthrough detection time (minutes) as per ASTM D 6978-
05Chemo Drug BUPS
(Polychlo)
BPZS
(Polychlo)
BENS
(Nitrile)
BUPS &
BENS*
(Double
Gloving
System)
BNPS
(Nitrile)
S-BFAP
(Polychlo)
BNPLS
(Nitrile)
CleanTough™
Fabric
Cisplatin
(Optional)
ND ND ND ND ND NT ND ND
Carmustine 2 50.3 12.4 ND 2.5 89.7 1.70 ND
Cyclophosphamide ND ND ND ND ND NT ND ND
Doxorubicin Hydrochloride ND ND ND ND ND NT ND ND
5-Fluorouracil ND ND ND ND ND NT ND ND
Methotrexate (Optional) ND ND ND ND ND NT ND ND
Etoposide ND ND ND ND ND NT ND ND
Paclitaxel ND ND ND ND ND NT ND ND
Thiotepa 47.7 107.7 30.5 ND 111 5.84 0.52 ND
Glove Use Outside The Pharmacy
Contact with cytotoxic drugs also occurs outside the pharmacy.
Primarily:
A) when being transported to point of use.
B) at point of use.
In both instances there is no requirement for sterile gloves, but there remains a requirement for protection against exposure to cytotoxic drugs.
Check gloves have the correct level of protection
Summary
• Understand the standards and how they impact on the operator for the choice of glove.
• Check the test results of glove for the application and area to be used.
• Ensure the Manufacturer conforms with the correct Quality System for the product manufactured.